Literature DB >> 7517889

Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death.

V Bruno1, A Copani, G Battaglia, R Raffaele, H Shinozaki, F Nicoletti.   

Abstract

(2S,1'R,2'R,3'R)-2-(2,3-Dicarboxycyclopropyl)glycine (DCG-IV), a potent agonist of subtypes 2 and 3 of metabotropic glutamate receptors (mGluR2 or 3), protected cultured cortical neurons against excitotoxicity induced either by a brief exposure to N-methyl-D-aspartate (NMDA) or a prolonged exposure to kainate. As a neuroprotective agent, DCG-IV was much more potent than the mixed agonists 1S,3R-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) or (2S,1'S,2'S)-2-(carboxycyclopropyl)glycine (L-CCG-I), suggesting a neuroprotective role for mGluR2 or 3 against excitotoxic neuronal death.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517889     DOI: 10.1016/0014-2999(94)90624-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection.

Authors:  Corrado Corti; Giuseppe Battaglia; Gemma Molinaro; Barbara Riozzi; Anna Pittaluga; Mauro Corsi; Manolo Mugnaini; Ferdinando Nicoletti; Valeria Bruno
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

2.  The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling.

Authors:  V Bruno; F X Sureda; M Storto; G Casabona; A Caruso; T Knopfel; R Kuhn; F Nicoletti
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

3.  Metabotropic glutamate receptor activation modulates kainate and serotonin calcium response in astrocytes.

Authors:  L L Haak; H C Heller; A N van den Pol
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

Review 4.  The modulation of calcium currents by the activation of mGluRs. Functional implications.

Authors:  A Stefani; A Pisani; N B Mercuri; P Calabresi
Journal:  Mol Neurobiol       Date:  1996-08       Impact factor: 5.590

5.  Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation.

Authors:  Adam G Walker; Douglas J Sheffler; Andrew S Lewis; Jonathan W Dickerson; Daniel J Foster; Rebecca K Senter; Mark S Moehle; Xiaohui Lv; Branden J Stansley; Zixiu Xiang; Jerri M Rook; Kyle A Emmitte; Craig W Lindsley; P Jeffrey Conn
Journal:  Neuropsychopharmacology       Date:  2017-06-30       Impact factor: 7.853

6.  Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.

Authors:  E Tatarczyńska; A Klodzińska; E Chojnacka-Wójcik; A Palucha; F Gasparini; R Kuhn; A Pilc
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

7.  Novel alternative splicing predicts a truncated isoform of the NMDA receptor subunit 1 (NR1) in embryonic rat brain.

Authors:  J M Campusano; M E Andrés; K Magendzo; J Abarca; L Tapia-Arancibia; G Bustos
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

8.  Ligand binding profile of the rat metabotropic glutamate receptor mGluR3 expressed in a transfected cell line.

Authors:  D J Laurie; M Danzeisen; H W Boddeke; B Sommer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

9.  Activation of metabotropic glutamate receptor subtype mGluR1 contributes to post-traumatic neuronal injury.

Authors:  A Mukhin; L Fan; A I Faden
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

10.  Protein kinase C and A3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins.

Authors:  T A Macek; H Schaffhauser; P J Conn
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.